MedTrace Logo

Developing Self-Management Interventions After HCT

NCT03710031 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2021-09-09

No results posted yet for this study

Summary

This is a prospective, longitudinal, observational trial to evaluate quality of life in hematopoietic stem cell transplant survivors.

Conditions

  • Hematopoietic Stem Cell Transplant (HSCT)

Interventions

OTHER

PNS Tracking

Through blood and stool samples the study team will track the interplay among PNS as they relate to diminished QOL. Symptoms tracked include neurocognitive dysfunction, fatigue, anxiety, depression and pain, inflammation (cytokines and C-reactive protein), gut microbiota \[(GM) richness and diversity\] and diet (macronutrients: carbohydrates, fats and proteins).

Sponsors & Collaborators

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • University of Florida

    lead OTHER

Principal Investigators

  • Debra L Kelly, PhD, RN, OCN · College of Nursing, University of Florida

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-04
Primary Completion
2021-07-31
Completion
2021-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03710031 on ClinicalTrials.gov